Abstract Purpose of Review Different treatment approaches have been described for the
management of COVID-19-related multisystem inflammatory syndrome in children (MIS-C) …

Knowledge on heparin-induced thrombocytopenia keeps increasing. Recent progress on
diagnosis and management as well as several discoveries concerning its pathogenesis …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare yet serious adverse
effect of the adenoviral vector vaccines ChAdOx1 nCoV-19 (AstraZeneca) and Ad26. COV2 …

Background This is a review article on heparin-induced thrombocytopenia, an adverse effect
of heparin therapy, and vaccine-induced immune thrombotic thrombocytopenia, occurring in …

Background Early recognition and treatment of heparin‐induced thrombocytopenia (HIT) are
key to prevent severe complications. Objective To assess the diagnostic performance of …

Heparin-induced thrombocytopenia (HIT) is caused by newly formed platelet-activating
antibodies against complexes formed between platelet factor 4 (PF4) and heparin (H). HIT …

Platelets play critical roles in hemostasis and thrombosis. While low platelet counts increase
the risk of bleeding, antithrombotic drugs, including anticoagulants and antiplatelet agents …

Objectives To measure CD62p and CD42b levels and to study its correlations with bleeding
score, and different prognostic factors in children with primary immune thrombocytopenia …

Heparin‐induced thrombocytopenia (HIT) is an antibody‐mediated adverse effect of
heparin. An emerging treatment in addition to alternative anticoagulation in severe HIT is …

Diagnosis of heparin induced thrombocytopenia (HIT) involves a comprehensive approach
combining clinical assessment and laboratory investigations. The 4T score system is …